Join to View Full Profile
13301 N Meridian AveSuite 501Oklahoma City, OK 73120
Phone+1 405-752-0871
Fax+1 405-755-9510
Dr. Hapani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sanjaykumar Hapani is an experienced Oncologist based in Oklahoma City. He finished his fellowship in Hematology and Medical Oncology and his residency in Internal Medicine at Stony Brook Medicine/University Hospital after graduating from B.J. Medical College - Ahmedabad. He currently works at Mercy Hospital Oklahoma City. Dr. Hapani has expertise in treating conditions such as amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma. His contributions to medical literature include several publications in reputed journals like Acta Oncologica, The New England Journal of Medicine and the Journal of Clinical Oncology.
Education & Training
Stony Brook Medicine/University HospitalFellowship, Hematology and Medical Oncology, 2009 - 2013- Stony Brook Medicine/University HospitalResidency, Internal Medicine, 2007 - 2010
B.J. Medical College AhmedabadClass of 2005
Certifications & Licensure
OK State Medical License 2013 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 36 citationsRisk of liver toxicity with the angiogenesis inhibitor pazopanib in cancer patients.Samir Kapadia, Sanjaykumar Hapani, Toni K. Choueiri, Shenhong Wu
Acta Oncologica. 2013-07-11 - 5 citationsImages in clinical medicine. Enlarged spleen with a heterogeneous pattern.Rosa Nouvini, Sanjaykumar Hapani
The New England Journal of Medicine. 2013-06-26 - Test Results Follow-Up: A Systematic ReviewShai Gavi, Vishal Ranpura, Sanjaykumar Hapani, Abdo Kataya, Bala Prakash
Journal of General Internal Medicine. 2013-02-01
Press Mentions
FDA Approves Drug to Help People Diagnosed with Rare Blood DiseaseNovember 21st, 2019- People Learn They Have Rare Blood Disease After Seeing Man's Story on KOCO 5November 13th, 2019
- Paralysis, Pain, Hallucinations: Oklahoma Man’s Rare Disease DiagnosedMay 10th, 2019
- Join now to see all
Professional Memberships
- Member
Other Languages
- Gujarati, Hindi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
